Estrella Immunopharma (ESLA) Deferred Taxes (2023)
Estrella Immunopharma (ESLA) posted quarterly Deferred Taxes of -$21102.0 for Q2 2023, up 2.76% quarter-over-quarter from -$21700.0 in Q1 2023.
Estrella Immunopharma (ESLA) Deferred Taxes (2023) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Deferred Taxes for 1 consecutive years, with -$21102.0 the latest figure, recorded in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | - |
| 10 | Estrella Immunopharma | 32.19 Mn | 32.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -21,102.00 |
| Mar 31, 2023 | -21,700.00 |